About PhysioLogic Devices
PhysioLogic Devices is a Healthcare company based in Los Angeles (United States) founded in 2014. Implantable insulin pump for diabetes treatment is being developed. PhysioLogic Devices offers products and services including Implantable Insulin Pump. Its focus areas include Life Sciences, Diabetes, Medical Devices and Therapeutic Devices. Its legal entity is PhysioLogic Devices, Inc. Its competitors include Admetsys, TypeZero Technologies and Pacific Diabetes Technologies; 3 of its 3 listed competitors have raised funding.
Company details
PhysioLogic Devices was founded in 2014 and is headquartered in Los Angeles, United States. Operations center on the medical device sector, where the ThinPump IP-IP is under development as an implantable insulin pump for diabetes management. Redundant sensors are integrated into the sidewall of the intraperitoneal catheter to enable full closed-loop control without user intervention. Animal implantation of a research prototype was scheduled for 2017.
- Headquarters Los Angeles, United States
- SectorsHealthcare
- Website physiologicdevices.com
- Legal Name Physiologic Devices, Inc.
- Latest Funding Round$222.1K (USD), Grant
Jun 2017
- Investors
Products & Services of PhysioLogic Devices
PhysioLogic Devices offers a comprehensive portfolio of products and services, including Implantable Insulin Pump.
Automatic system for delivering insulin and monitoring glucose in diabetes patients.
Funding Insights of PhysioLogic Devices
- Total Rounds 1
- Last Round Grant — $222,099
- First Round $222,099
(Jun 2017)
- Investors Count 1
All 1 funding rounds of PhysioLogic Devices with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2017 | $222,099 | Grant | – | – |
1 investors in total: 1 institutional.
Investors in PhysioLogic Devices
PhysioLogic Devices has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov |
Investor details for PhysioLogic Devices
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of PhysioLogic Devices
4 people are tracked at PhysioLogic Devices (3 in leadership, 1 in team).
| Name | Role | Group |
|---|---|---|
Stacy Chambliss | Chief Executive Officer | Leadership |
Lee Hartley | Chief Technology Officer | Leadership |
Austin Smith | Head Of Engineering | Leadership |
Katrina Finley-Montero | Senior Test Engineer | Team |
Complete people profiles for PhysioLogic Devices
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of PhysioLogic Devices
2 dated milestones of PhysioLogic Devices across 3 years, from founding to its latest funding, stage changes and deals.
- Founded PhysioLogic Devices is founded.
- Funding First funding round of $222K.
Competitors of PhysioLogic Devices
PhysioLogic Devices has 3 listed competitors in our database, 3 of them funded. They include Admetsys, TypeZero Technologies and Pacific Diabetes Technologies.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| admetsys.com | 2014 | Boston, United States | $50,000 | Provider of a closed-loop system for insulin and glucose delivery | ||
| typezero.com | 2013 | Charlottesville, United States | $415,000 | Device for continuous glucose monitoring with manually operated insulin delivery | ||
| pacificdt.com | 2011 | Portland, United States | $6.52M | Electronic diabetes management device for glucose sensing and hormone delivery |
Detailed competitors of PhysioLogic Devices
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Diabetes
3 companies that operate in the same segment as PhysioLogic Devices (Diabetes) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of devices for continuous glucose monitoring and manual insulin delivery | 2008 | San Diego, California, United States | USD 100.73 M | USD 1.02 B | 2,650 | |
Wearable glucose monitoring patches are provided for real-time data tracking. | 1999 | San Diego, California, United States | USD 52.5 M | USD 4.66 B | 10,300 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about PhysioLogic Devices
PhysioLogic Devices was founded in 2014 and raised its 1st funding round 3 years after it was founded.
PhysioLogic Devices is headquartered in Los Angeles, United States. It is registered at Los Angeles, California, United States.
PhysioLogic Devices was founded in 2014 and is headquartered in Los Angeles, United States. Operations center on the medical device sector, where the ThinPump IP-IP is under development as an implantable insulin pump for diabetes management. Redundant sensors are integrated into the sidewall of the intraperitoneal catheter to enable full closed-loop control without user intervention. Animal implantation of a research prototype was scheduled for 2017.
PhysioLogic Devices's top competitors include Admetsys, TypeZero Technologies and Pacific Diabetes Technologies.
PhysioLogic Devices offers Implantable Insulin Pump.
PhysioLogic Devices has 1 investor. Key investors include HHS.
PhysioLogic Devices operates through Physiologic Devices, Inc..